Post photorefractive keratectomy (PRK) infectious keratitis; six-year experience of a tertiary eye hospital.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
03 2023
Historique:
received: 23 07 2021
accepted: 22 02 2022
revised: 07 02 2022
pmc-release: 01 03 2024
pubmed: 12 3 2022
medline: 14 3 2023
entrez: 11 3 2022
Statut: ppublish

Résumé

As an essential development in the new century, surface ablation procedures have attracted increasing attention. There exists a concern regarding the risk of infectious keratitis. Hence, we aimed to investigate the rate and predisposing factors of infectious keratitis after photorefractive keratectomy (PRK). This retrospective study was designed in two phases. First, the rate of post-PRK keratitis of Farabi Eye Hospital was investigated. In other words, the targeted population was the patients who developed keratitis after performing procedure at Farabi Eye Hospital. In the second phase, all the patients with the diagnosis of post-PRK keratitis were studied regardless of the centre where surgery was performed. Patients with the diagnosis of infectious keratitis between 2014 and 2020 were enrolled and following information was analyzed: demographics, presentation time after surgery, perioperative medications, culture results, risk factors, medical treatment, complications, and final visual acuity. The total number of PRK procedures in our centre was 24,986 (13,253 patients), in which 6 eyes of 5 patients developed keratitis. Beside these 5 patients, 24 referred patients (24 eyes) from the other centres were enrolled. Finally, a total number of 29 patients (30 eyes) were included. Our analysis revealed that manipulation of contact lens, dry eye, and blepharitis were the essential predisposing factors for keratitis development. The overall post-PRK keratitis occurrence rate of our study was 0.02%. Our observation highlighted the importance of preoperative examination and treatment of the lids and dry eye disease.

Sections du résumé

BACKGROUND/OBJECTIVES
As an essential development in the new century, surface ablation procedures have attracted increasing attention. There exists a concern regarding the risk of infectious keratitis. Hence, we aimed to investigate the rate and predisposing factors of infectious keratitis after photorefractive keratectomy (PRK).
SUBJECTS/METHODS
This retrospective study was designed in two phases. First, the rate of post-PRK keratitis of Farabi Eye Hospital was investigated. In other words, the targeted population was the patients who developed keratitis after performing procedure at Farabi Eye Hospital. In the second phase, all the patients with the diagnosis of post-PRK keratitis were studied regardless of the centre where surgery was performed. Patients with the diagnosis of infectious keratitis between 2014 and 2020 were enrolled and following information was analyzed: demographics, presentation time after surgery, perioperative medications, culture results, risk factors, medical treatment, complications, and final visual acuity.
RESULTS
The total number of PRK procedures in our centre was 24,986 (13,253 patients), in which 6 eyes of 5 patients developed keratitis. Beside these 5 patients, 24 referred patients (24 eyes) from the other centres were enrolled. Finally, a total number of 29 patients (30 eyes) were included. Our analysis revealed that manipulation of contact lens, dry eye, and blepharitis were the essential predisposing factors for keratitis development.
CONCLUSION
The overall post-PRK keratitis occurrence rate of our study was 0.02%. Our observation highlighted the importance of preoperative examination and treatment of the lids and dry eye disease.

Identifiants

pubmed: 35273348
doi: 10.1038/s41433-022-02009-2
pii: 10.1038/s41433-022-02009-2
pmc: PMC9998852
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

631-637

Informations de copyright

© 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Références

Ophthalmology. 2005 May;112(5):888-95
pubmed: 15878072
J Refract Surg. 2006 Feb;22(2):159-65
pubmed: 16523835
Surv Ophthalmol. 2004 May-Jun;49(3):269-80
pubmed: 15110665
Ophthalmology. 2008 Oct;115(10):1647-54, 1654.e1-3
pubmed: 18597850
Am Fam Physician. 2001 Oct 1;64(7):1183-90
pubmed: 11601800
J Refract Surg. 2010 Mar;26(3):209-16
pubmed: 20229954
J Cataract Refract Surg. 2007 Mar;33(3):474-83
pubmed: 17321399
J Cataract Refract Surg. 2011 Jul;37(7):1343-50
pubmed: 21700112
J Cataract Refract Surg. 2008 Sep;34(9):1439-50
pubmed: 18721702
J Cataract Refract Surg. 2011 Oct;37(10):1822-31
pubmed: 21865006
Clin Exp Ophthalmol. 2010 Mar;38(2):183-91
pubmed: 20398107
J Cataract Refract Surg. 2017 Apr;43(4):473-479
pubmed: 28532931
J Cataract Refract Surg. 2003 Jan;29(1):222-3
pubmed: 12551696
Am J Ophthalmol. 2001 Nov;132(5):779-80
pubmed: 11704041
Lancet. 1999 Jul 17;354(9174):181-5
pubmed: 10421298
Graefes Arch Clin Exp Ophthalmol. 1998 Oct;236(10):721-4
pubmed: 9801884
J Cataract Refract Surg. 2000 Jan;26(1):140-1
pubmed: 10646160
J Refract Surg. 1998 Nov-Dec;14(6):631-5
pubmed: 9866102
J Refract Surg. 2005 Jan-Feb;21(1):96
pubmed: 15724694
Indian J Ophthalmol. 2006 Mar;54(1):23-7
pubmed: 16531666
Clin Ophthalmol. 2020 Nov 16;14:3891-3901
pubmed: 33235430
Arch Ophthalmol. 1995 Dec;113(12):1479-96
pubmed: 7487614
J Refract Surg. 2006 Apr;22(4):404-6
pubmed: 16629075
Curr Opin Ophthalmol. 2014 Jul;25(4):251-7
pubmed: 24837576
Ophthalmology. 2018 Jan;125(1):P1-P104
pubmed: 29108748
J Cataract Refract Surg. 2007 Oct;33(10):1734-7
pubmed: 17889768
J Ophthalmol. 2020 Jul 28;2020:6329321
pubmed: 32774907
J Ophthalmic Vis Res. 2012 Apr;7(2):162-6
pubmed: 23275825
Ophthalmology. 2003 Apr;110(4):743-7
pubmed: 12689896
Am J Ophthalmol. 2007 Apr;143(4):629-34
pubmed: 17320811
Curr Opin Ophthalmol. 2014 Jul;25(4):270-4
pubmed: 24837579
Ophthalmology. 2006 Apr;113(4):520-5
pubmed: 16488012
J Optom. 2015 Jul-Sep;8(3):149-69
pubmed: 25444646

Auteurs

Mohammad Soleimani (M)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Keykhaei (M)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Seyed Ali Tabatabaei (SA)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Mansoor Shahriari (M)

Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Hossein Farrokhpour (H)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Bahareh Ramezani (B)

School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Kasra Cheraqpour (K)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. Cheraqpourk@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH